MAP Kinase Signaling
MEK1/2 Antibody
|
イイネ！(3)
| 
|
| CSTコード |
包装 |
希望納入価格 (円) |
国内在庫  |
ご登録代理店情報 カスタマー情報にご登録いただいた代理店を表示しています。
ご登録代理店の変更は こちら。 |
| #9122S | 100 μL | 46,000 | |
|
| #9122L | 300 μL | 111,000 | |
MEK1/2抗体製品一覧
9122 の推奨プロトコール
最適な結果を得るために：Cell Signaling Technology (CST) 社は、各製品の推奨プロトコールを使用することを強くお薦めいたします。
推奨プロトコールはCST社内試験の徹底的なバリデーションに基づいて作成されておりますので、正確かつ再現性の高い結果が得られます。
注：各製品に最適化されたプロトコールをリンクしています。
| | |
-
9122:
-
Immunoprecipitation
Western Blotting
| 用途（希釈倍率） | |
| ウェスタンブロッティング（1:1,000）、免疫沈降（1:50） |
| 種交差性 | |
| ヒト、マウス、ラット、サル、キイロショウジョウバエ、（アフリカツメガエル） |
| 特異性・感度 | |
| 内在性レベルのMEK1/2 タンパク質を検出します。SEK (MKK4)、MKK3、MKK6 タンパク質などの関連キナーゼとは交差しません。 |
| 使用抗原 | |
| ヒトのMEK1/2 タンパク質由来の配列（合成ペプチド） |
| ※括弧付きの動物種は配列が100%相同であるため反応すると推定されます。 |
Western Blotting
Western blot analysis of extracts from untreated, TPA-treated or lambda phosphatase-treated HeLa cells, using Phospho-MEK 1/2 (Ser217/221) Antibody #9121 (upper) or MEK 1/2 Antibody #9122 (lower).
MEK1 and MEK2, also called MAPK or Erk kinases, are dual-specificity protein kinases that function in a mitogen activated protein kinase cascade controlling cell growth and differentiation (1-3). Activation of MEK1 and MEK2 occurs through phosphorylation of two serine residues at positions 217 and 221, located in the activation loop of subdomain VIII, by Raf-like molecules. MEK1/2 is activated by a wide variety of growth factors and cytokines and also by membrane depolarization and calcium influx (1-4). Constitutively active forms of MEK1/2 are sufficient for the transformation of NIH/3T3 cells or the differentiation of PC-12 cells (4). MEK activates p44 and p42 MAP kinase by phosphorylating both threonine and tyrosine residues at sites located within the activation loop of kinase subdomain VIII.
-
Crews, C.M. et al. (1992) Science 258, 478-480.
-
Alessi, D.R. et al. (1994) EMBO J. 13, 1610-1619.
-
Rosen, L.B. et al. (1994) Neuron 12, 1207-1221.
-
Cowley, S. et al. (1994) Cell 77, 841-852.
- Fei, Z. et al. (2011) J Biol Chem 286, 27761-8. Applications: Western Blotting
- Thompson, T. et al. (2010) Mol Cancer Ther 9, 1158-68. Applications: Western Blotting
- Piatelli, M. J. et al. (2004) Phosphatidylinositol 3-kinase-dependent mitogen-activated protein/extracellular signal-regulated kinase kinase 1/2 and NF-kappa B signaling pathways are required for B cell antigen receptor-mediated cyclin D2 induction in mature B cells. J. Immunol. 172, 2753-2762. Applications: Western Blotting
- Umenishi, F. and Schrier, R.W. (2003) Hypertonicity-induced aquaporin-1 (AQP1) expression is mediated by the activation of MAPK pathways and hypertonicity-responsive element in the AQP1 gene. J. Biol. Chem. 278, 15765-15770. Applications: Western Blotting
- Rosenberger, C.M. and Finlay, B.B. (2002) Macrophages Inhibit Salmonella Typhimurium Replication through MEK/ERK Kinase and Phagocyte NADPH Oxidase Activities. The Journal of Biological Chemistry 277, 18753-18762. Applications: Western Blotting
- Deszo, E. L. et al. (2001) Cd45 negatively regulates monocytic cell differentiation by inhibiting phorbol 12-myristate13-acetate-dependent activation and tyrosine phosphorylation of C70protein kinase cdelta. Journal of Biological Chemistry 276, 10212-10217. Applications: Western Blotting
- Furuno, T. et al. (2001) Nuclear shuttling of mitogen-activated protein (map) kinase (extracellular signal-regulated kinase (erk) 2) was dynamically controlled by map/erk kinase after antigen stimulation inrbl-2h3 cells. Journal of Immunology 166, 4416-4421. Applications: IC-IF Western Blotting
- Bueno, O. F. et al. (2000) The MEK1-ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice. European Molecular Biology Organization (EMBO) 19, 6341-6350. Applications: Western Blotting
- Oneyama, C. (2008) Mol Cell 30, 426-36. Applications: Western Blotting
